Trump’s Bold Move: What It Means for Global Health! Are U.S. Firms Afraid of China?
In this week's episode of the engaging biotech podcast “The Readout LOUD,” critical issues in health and drug development take center stage. The conversation kicks off with reflections on the…
Biogen’s Bold Move: Leadership Changes and Workforce Cuts Ahead
Restructuring Within Biogen's Research Division In a strategic shift following a challenging year, Biogen’s newly appointed research leader, Jane Grogan, Ph.D., is implementing significant adjustments to the company's research team.…
Is Biotechnology the New Battlefield? The U.S. Takes Action
The technological race between the United States and China intensifies as the U.S. imposes strict export controls on biotechnology. The Department of Commerce has implemented new rules aimed at safeguarding…
BNN Faces Setbacks: Revenue Declines and Losses Widening
**A rough year for BRAIN Biotech has resulted in declining revenue and increasing net losses.** The company reported a revenue of €55.5 million for the fiscal year, reflecting a minor…
Massive Deal Alert! This New Biotech Company Is Making Waves
**Investment firm RTW Investments has launched a cutting-edge biotech venture named Prolium Bioscience, aimed at revolutionizing treatment for certain cancers.** With a strategic focus on a promising CD20×CD3 bispecific antibody,…
Massive Funding Deals Unfolding! Discover the Giants of Startup Investment
### Major Startup Funding Highlights This Week Investors are making waves in the startup ecosystem as 2024 starts off strong with significant funding rounds. This week continues to showcase major…
BRAIN Biotech’s Yearly Report: A Mixed Bag of Surprises! Are Analysts Losing Faith?
### BRAIN Biotech's Latest Performance Shakes Investor Confidence BRAIN Biotech AG (ETR:BNN) unveiled its annual report, revealing disappointing financial results. The company reported revenues of **€55 million**, falling short of…
Is This the Next Big Player in Global Biotech? Discover What’s Brewing
Jiangsu Hengrui Pharmaceuticals Sets Global Aspirations In a recent presentation at the prestigious J.P. Morgan Healthcare Conference, Jiangsu Hengrui Pharmaceuticals showcased its ambitious plans to expand its influence beyond China.…
New High-Tech Export Controls: What You Need to Know
Important changes are coming to U.S. export laws! On Wednesday, the U.S. Department of Commerce revealed plans to impose new restrictions on the export of specific biotechnology equipment, driven by…
Major Change Alert for Evaxion Investors! Discover What Happens Next
Evaxion Trajectory Shift Evaxion Biotech (NASDAQ: EVAX) has just implemented a significant change to its American Depositary Shares (ADS) ratio, set in motion from January 14, 2025. Previously, each ADS…